We are live on ! Find out more
GS

Gagnon Securities Portfolio holdings

AUM $519M
1-Year Est. Return 44.91%
This Fund
S&P 500
This Quarter Est. Return
+51.16%
1 Year Est. Return
+44.91%
3 Year Est. Return
+129.38%
5 Year Est. Return
+108.07%
10 Year Est. Return
+1,389.15%
AUM
$413M
AUM Growth
+$119M
Cap. Flow
-$6.63M
Cap. Flow %
-1.61%
Top 10 Hldgs %
47.66%
Holding
105
New
9
Increased
20
Reduced
52
Closed
14

Top Sells

Rank Stock Value
1
FLXN
Flexion Therapeutics, Inc.
FLXN
+$5.48M
2
AMRC icon
Ameresco
AMRC
+$2.04M
3
BL icon
BlackLine
BL
+$1.85M
4
ONTO icon
Onto Innovation
ONTO
+$1.77M
5
QDEL icon
QuidelOrtho
QDEL
+$1.15M

Sector Composition

Rank Sector Weight
1 Healthcare 33.26%
2 Technology 20.83%
3 Industrials 17.53%
4 Consumer Discretionary 10.34%
5 Energy 5.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PSIX
26
Power Solutions International
PSIX
$773M
$4.44M 1.08%
1,110,006
+159,710
+17% +$639K
GFNCP
27
DELISTED
General Finance Corporation Cumulative Redeemable Perpetual Preferred Series C
GFNCP
$4.31M 1.04%
44,877
-617
-1% -$57.9K
WPX
28
DELISTED
WPX Energy, Inc.
WPX
$4.3M 1.04%
674,804
-5,634
-0.8% -$31.8K
PNTG icon
29
Pennant Group
PNTG
$1.35B
$4.27M 1.03%
189,074
-7,211
-4% -$151K
CTRE icon
30
CareTrust REIT
CTRE
$9.73B
$3.59M 0.87%
209,461
-5,016
-2% -$87.6K
CSLT
31
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$3.5M 0.85%
4,218,670
+147,016
+4% +$109K
BLFS icon
32
BioLife Solutions
BLFS
$1.67B
$2.63M 0.64%
+161,076
New +$2.22M
FLXN
33
DELISTED
Flexion Therapeutics, Inc.
FLXN
$2.59M 0.63%
196,707
-528,017
-73% -$5.48M
CELC icon
34
Celcuity
CELC
$4.62B
$2.52M 0.61%
364,339
+167,462
+85% +$1.18M
AKAM icon
35
Akamai
AKAM
$17.5B
$2.4M 0.58%
22,395
-100
-0.4% -$10.1K
DRRX
36
DELISTED
DURECT Corp
DRRX
$2.35M 0.57%
101,143
-9,863
-9% -$217K
AL.PRA
37
DELISTED
Air Lease Corp 6.150% Series A Preferred Stock
AL.PRA
$2.23M 0.54%
+109,352
New +$2.11M
ZUO
38
DELISTED
Zuora, Inc.
ZUO
$2M 0.48%
156,625
+118
+0.1% +$1.31K
GNRC icon
39
Generac Holdings
GNRC
$13.1B
$1.73M 0.42%
14,183
-77
-0.5% -$8.11K
APEN
40
DELISTED
Apollo Endosurgery, Inc.
APEN
$1.56M 0.38%
952,677
-58,779
-6% -$117K
TLND
41
DELISTED
Talend S.A. American Depositary Shares
TLND
$1.5M 0.36%
43,309
+151
+0.3% +$4.45K
RDHL
42
Redhill Biopharma
RDHL
$4.07M
$1.41M 0.34%
210
+111
+112% +$764K
CNF
43
CNFinance Holdings
CNF
$37.6M
$1.34M 0.33%
34,812
-441
-1% -$16.8K
TFFP
44
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
$1.27M 0.31%
+8,808
New +$1.11M
T icon
45
AT&T
T
$161B
$1.26M 0.31%
55,272
+33,181
+150% +$756K
GNTX icon
46
Gentex
GNTX
$5.04B
$1.11M 0.27%
42,947
-92
-0.2% -$2.31K
MCHP icon
47
Microchip Technology
MCHP
$42.9B
$1.06M 0.26%
20,112
+2
+0% +$90
XOM icon
48
ExxonMobil
XOM
$632B
$823K 0.2%
18,407
+11,544
+168% +$518K
IPHI
49
DELISTED
INPHI CORPORATION
IPHI
$795K 0.19%
6,768
-4,993
-42% -$526K
PYPL icon
50
PayPal
PYPL
$50.3B
$688K 0.17%
3,951

Similar funds

Gagnon Securities's Q2 2020 Portfolio in Review

As of Q2 2020, Gagnon Securities held 105 positions worth $413M, up 40% from $294M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Gagnon Securities's Q2 2020 filing shows 9 new, 20 increased, 52 reduced and 14 closed positions. Its largest new stake was BioLife Solutions: 161,076 shares worth $2.63M. The largest sale was Flexion Therapeutics, Inc., an estimated $5.48M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 32% a quarter earlier, followed by Technology and Industrials.

  • Gagnon Securities's largest Q2 2020 buy was BioLife Solutions: 161,076 shares worth $2.63M.
  • Gagnon Securities added most to Navigator Holdings in Q2 2020, an estimated $2.77M increase.
  • Gagnon Securities's biggest Q2 2020 reduction was Flexion Therapeutics, Inc., cutting an estimated $5.48M.
  • Gagnon Securities fully exited eHealth in Q2 2020, selling an estimated $421K.
  • Gagnon Securities's ten largest holdings make up 48% of its $413M portfolio in Q2 2020.
  • Gagnon Securities opened 9 new positions and closed 14 in Q2 2020.
  • Gagnon Securities's portfolio value rose 40% quarter-over-quarter to $413M.

Based on Gagnon Securities's 13F filing for Q2 2020, filed 13 Aug 2020.